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Introduction: to identify the pattern-reversal visual evoked potential (PRVEP) waveform descriptor by 
evaluating discrete wavelet transform (DWT) in order to optimize stimulus in the diagnosis of 
anisometropia amblyopia. 
Materials and Methods: The PRVEP testing was performed for 31 normal individuals and 35 patients 
with amblyopia. The stimuli were consisted of spatial frequencies of 1, 2, and 4 cycles per degree (cpd) 
and contrast levels of 100%, 50%, 25%, and 5%. The results were analyzed in the dimensions of time 
and time-frequency. DWT descriptor were extracted at level 7 (7P descriptor) for Haar, Daubechies 2, 
Daubechies 4, Symlet 5, Biorthogonal 3.5, Biorthogonal 4.4, and Coiflet 5 wavelets for 12 stimuli and 
compared between the two groups.  The correlation between different spatial frequencies at the same 
contrast level and the similarities between reconstructed signals and original waveforms were 
evaluated. 
Results: There were a significant reduction in P100 amplitude and a significant elevation in latency 
among the patient group. In the patients with amblyopia, 7P descriptor decreased in all analysis except 
for the frequency of 4 cpd and the contrast of 5% using bior4.4. No significant correlation was 
observed between different frequencies at a special contrast; however, there was a significant 
correlation between reconstructed signals and the original ones. 
Conclusion: The 7P descriptor could be used to distinguish between normal and abnormal signals in 
anisometropia amblyopia. Considering the results, DWT with coif5, db4, bior4.4, and bior3.5 wavelets 
can be utilized as a good indicator for selecting optimum stimulus. 
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Introduction 
Uni- or bilateral developmental disorder of spatial 
vision due to binocular vision anomalies and reduced 
visual acuity is defined as amblyopia. It is caused by 
visual deprivation, strabismus, or anisometropia 
(difference in the refractive error of the two eyes) [1-5]. 
The prevalence of amblyopia is estimated to be 
between 1.6% and 3.5% of the population [5]. 
According to the literature, amblyopia is a complicated 
mechanism of brain information processing deficit [6, 
7]. Several methods have been used for years to localize 
amblyopia deficits such as positron emission 
tomography, functional magnetic resonance imaging, 
and electrophysiology study [8-11]. 
Regarding the results of neurological studies, 
amblyopia might be initiated from the malfunctioning 
of the primary visual cortex (V1). Nevertheless, 
several studies indicated that extra striate cortex is 
responsible for spatial visual malfunction [8]. In 
addition, such impairments can be observed in higher 
visual areas [12].  
Visual evoked potentials (VEP) record 
electrophysiological signals of the V1 activity in 
response to visual stimuli [13]. The VEP is an objective 
and efficient diagnostic method representing visual 
system activity in visual cortex level that evaluates the 
function of the entire visual pathway [1, 14, and 15]. 
The investigations carried out into the use of VEP in 
amblyopia aimed to determine the mechanism of 
visual acuity reduction and localize the site of the 
main defects [16]. The time domain analysis of pattern 
VEP (PVEP) of patients with amblyopia showed its 
efficacy for clinical diagnosis of amblyopia [16-18]. 
Additionally, the analysis of amplitude and latency of 
PVEP in time domain can be used to predict the 
effectiveness of therapy in amblyopia [19, 20]. Pattern 
reversal is the optimum stimulus because of its 
simplicity, little waveform variation, and stability [21]. 
The PRVEP consists of N75, P100, and N135, which 
are designating peaks as negative, positive, and 
occurrence time. The P100 is the most prominent and 
strongest peak in VEP. It has minimal variation and 
high repeatability. The P100 is affected by stimulus 
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parameters such as pattern, pattern contrast, and 
mean luminance, etc. [4, 13, 22]. 
The activity of two or more parallel pathways from 
retina to the V1 causes VEP. The V1 receives parallel 
inputs from magnocellular (M) and parvocellular (P) 
pathways [23]. The neurons of the M pathway are 
sensitive to low spatial and high temporal frequencies 
and saturated in low contrast, whereas P pathway 
neurons are affected by high spatial and low temporal 
frequencies and saturated in high contrasts [24, 25].  
Both M and P pathways are the sources of the VEP 
amplitude at high-luminance contrasts [26]. 
Anisometropia amblyopia affects both pathways; 
therefore, the patients suffering from this disorder 
have abnormal response to high and low spatial 
frequencies [4, 8]. The wavelet transform (WT) is a 
powerful time-frequency approach in biosignals 
processing, denoising, and compressing. It has two 
forms of continuous wavelet transform (CWT) and 
discrete wavelet transform (DWT) [27, 28]. The main 
advantage of wavelet is its variable window size that 
leads to an optimum time-frequency resolution 
adopted to all frequencies [29]. This modern approach 
was typically applied for multidimensional biosignals 
analysis by electromyography, 
electroencephalography (EEG), and 
electrocardiography; however, it is rarely used in 
visual signals analysis [27, 28]. Up until now, steady-
state VEP, multifocal VEP, transient VEP (TVEP), and 
VEP have been denoised and analyzed using the WT 
[30-38]. In addition, the WT is used to denoise EEG 
and extract evoked potentials [38, 39].   
Clinical tests demonstrated that multiresolution 
analysis can indicate the peak latency of VEP [33]. 
Sivakumar et al. in 2006 denoised TVEP and analyzed 
its negative and positive  peaks with different 
wavelets. They showed that P100 (positive peak) was 
more apparent in denoised version of signal using 
Biorthogonal 3.5 (bior3.5) and Symlet 5 (sym5) 
wavelets [34].  
Akbari and Azmi in 2011 utilized Haar, Daubechies 
2 (db2), and Daubechies 4 (db4) wavelets to extract 
the features of VEP for classifying by k-nearest 
neighbor and support network machine algorithms. 
Their findings indicated that proper features obtained 
from WT of VEP can separate normal and abnormal 
subjects; moreover, db4 had the best accuracy in this 
method [35]. The CWT of VEP with Mexican hat 
wavelet was performed to obtain automatic 
processing and classification of VEP. The results 
showed more reliable separating normal and 
pathologic cases [36].  
In a study conducted by Almurshedi et al.in 2015, 
Coiflet 5 (coif5) wavelet was utilized to denoise the 
VEP signals and increase signal to noise ratio (SNR). 
According to the results of the comparison between 
WT findings and principal component analysis, higher 
SNR in WT, as well as flexibility and capability of WT 
for VEP analyzing and its sub-band decomposition 
were observed [37]. 
To the best of our knowledge, the studies carried 
out into VEP assessed only the time and the frequency 
domains for different diseases [2, 17, 18, 23, 40-44]. 
The WT of VEP is used for classification and /or 
denoising; nevertheless, there was no attempt to find 
descriptor by the DWT of VEP in amblyopia. This 
study sought to extract a descriptor from DWT of 
PRVEP by functional specialization of visual stimuli 
and scanning scalograms for various wavelets. This 
descriptor may detect possible deficits in visual 
processing pathways and find out optimum contrast 
and spatial frequency that lead to the diagnosis of 
anisometropia amblyopia. 
 
Materials and Methods 
This study was conducted on 31 normal individuals 
and 35 patients with amblyopia including 31 subjects 
with unilateral and 2 subjects with bilateral amblyopia. 
A total of 14 women and 21 men aged between 16 and 
35 years old participated in this study. An informed 
consent was obtained from all the participants, and 
they were referred after performing eye examination 
by an ophthalmologist and an optometrist. Acceptable 
visual acuity (Log Mar) was considered to be between 
0.3 and 0.1. The PRVEP signals were recorded by 
Metrovision Monpack one (Metrovision Company, 
Pérenchies, France) with gold plated cupula electrodes, 
which were placed according to the international 10-20 
system. 
All the PRVEPs were done considering the 
International Society for Clinical Electrophysiology of 
Vision protocols. Checkerboard stimulus was displayed 
with a contrast reversal rate of 2.5 times per second, 
amplification of 2000 times, and band pass filter of 1-
100 Hz. In this study, the stimuli were consisted of 
element sizes of 30º, 15º, and 7º arc (equal to spatial 
frequencies of 1, 2 and 4 cycles per degree (cpd), 
respectively) and four contrast levels of 100%, 50%, 
25%, and 5% on each spatial frequency. The VEPs were 
stored at a 1024 sampling frequency using 240 
samples. The number of sweeps per average was 60. 
Data were transported to the MATLAB software 
(MATLAB R2015b) to perform time and time-
frequency domains analysis. After evaluating the P100 
amplitudes and latencies in the time domain of all VEPs, 
normalization and discrete WT of VEPs were carried 
out using the Wavelet Toolbox software. 
 
Data Analysis 
DWT is an efficient method introduced by Mallat 
that employs a dyadic grid (integer powers of two 
scaling in a and b). 
                                   (1) 
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Where  Tm,n denotes localized wavelet coefficients in 
discrete scales m (frequency) and discrete moments n 
(time), x (t) represents the original signal in the time 
domain, and Ψ designates the wavelet function [45, 46]. 
After a full decomposition, the energy content of the 
coefficients at each scale was computed by equation. 
                                                      (2) 
 
Where Tm,n was considered as DWT, m was the scale 
integer, and n controlled wavelet translation. The 
summation of squared detail coefficients and the 
square of the remaining approximation coefficients 
(SM,0) was equal to the total energy of the input signal 
[46]. 
                                       (3) 
 
The wavelets used to analyze the PRVEP waveforms 
were Haar, db2, db4, sym5, bior3.5, bior4.4, and coif5. 
The frequencies covered by levels less than 7 were 
higher than the PRVEP frequencies; therefore, the 
coefficients of these bands were discarded in all cases. 
The DWT scalogram was represented by three axes 
including x-axis (time), y-axis (frequency or scale), and 
z-axis (wavelet coefficient value or energy) that were 
demonstrated by different colors. Time intervals, 
frequency of signal components, and energy 
distribution of wavelet coefficients can be identified by 
scalogram analysis [47, 48]. Scalogram analysis allows 
selecting single coefficient related to P100  peak. 
We computed the energy percentage of a single 
wavelet coefficient to the total energy of level 7 in 
predetermined time intervals in this level (low 
frequency level) for all above mentioned wavelets by 
12 stimuli. Figures 1a and 1b show normal signals in 
time domain and their descriptor extraction from DWT 
scalogram using coif5 wavelet. Rectangle with white 
border shows 7P descriptor in level 7. 
Regarding the results of component extracted from 
the DWT scalograms of normal waveforms, normal and 
abnormal groups were compared. Finally, signal 
reconstruction was done with level 7 coefficients using 
wavelets with significantly different descriptors. 
Data analysis was performed using Kolmogorov-
Smirnov and independent samples t-test with the help 
of SPSS software, version 22, and effect size was 
measured using Cohen’s d. Finally, Pearson’s 
correlation coefficient was applied to compare the 
similarities between reconstructed signals and original 
VEP waveforms and to evaluate the correlation 
between different spatial frequencies at the same 
contrast level. In all the measurements, P-value less 
than 0.05 were considered statistically significant. 
 
 
 
 
Results 
The results obtained from the time domain 
analysis of P100 amplitude and latency are 
represented in tables 1a and 1b. According to the 
results, the P100 amplitude at spatial frequency of 1 
cpd in all contrasts significantly decreased in the 
patients group (P<0.03). Additionally, this reduction 
was observed at 2 cpd spatial frequency in all 
contrasts, except for the contrast of 5%. Nonetheless, 
at spatial frequency of 4 cpd, amplitude decreased 
only in maximum and minimum contrasts. The P100 
latency increased only at 30º arc at the contrasts of 
50% and 25%. 
The results of the DWT descriptor of PRVEPs 
using various wavelets are demonstrated in Table 2. 
The comparison of obtained results between normal 
and patients groups revealed significant differences 
in the contrasts of 50% and 100% only in the spatial 
frequencies of 2 cpd 4 cpd, respectively. However, all 
three frequencies had significant differences at the 
contrast of 5%.  As shown in Table 2, the frequency 
of 2 cpd at the contrasts of 50% and 5% had the most 
significant differences followed by frequency of 4 cpd 
at the contrasts of 100% and 25%. Among the 
selected wavelets, coif5, db4, bior4.4, bior3.5, and 
sym5 showed significant reduction between the 
descriptors of two groups. The 7P decreased at the 
frequency of 1 cpd and the contrast of 5% using coif5 
wavelet. However, the 7P increased in the patient 
group only at the frequency of 4 cpd and the contrast 
of 5%, which were analyzed by bior4.4 (P<0.03). 
The variables that show significant P-values 
overlapped in time and time-frequency domains are 
presented in Table 3. In these two domains, the 
frequency of 2 cpd and the contrast of 50% had the 
most significant differences followed by 4 cpd and 
100%. Moreover, the contrast of 5% in two 
frequencies of 1 cpd and 4 cpd had significant 
difference in both domains and higher P-value in 
wavelet and time domain, respectively. 
The analysis of normal and abnormal signals in 
time and time-frequency domains is demonstrated in 
Figure 2. According to the DWT scalogram, the 
energy percentage of detail coefficients related to 
P100 peak decreased in abnormal signals.  
Regarding the results, there was no significant 
correlation between the frequencies of 1 cpd and 2 
cpd at the contrast of 5% for db4 and between the 
frequencies of 2 cpd and 4 cpd at the contrast of 25% 
for bior4.4 (Table 4; r=0.299, r=0.259). Furthermore, 
no significant correlation was observed between the 
frequencies of 2 cpd and 4 cpd at the contrast of 25% 
for coif5 wavelet (r=0.244). The significant 
correlations are presented in Table 4. 
According to the results of the Pearson’s 
correlation coefficient test, there was a significant 
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correlation between the two normal and pathological 
waveforms (r= 0.882, r=0.914). Figure 3 is an 
example of reconstructed normal and abnormal 
signals using coif5 at the frequency of 1 cpd and the 
contrast of 5%. 
 
 
Table1. Significant results of the comparison of mean amplitudes (a) and latency (b) of P100 peak between normal and abnormal signals 
in time-domain analysis  
 
P-value Normal (mean±SD) Patient (mean±SD*) P100 amplitude (µV) 
0.014 13.89±7.88 9.63±6.00 Frequency of 1 cpd, contrast of 100%, size of 30  
0.035 11.27±6.42 8.30±4.87 Frequency of 1cpd contrast 50% size 30 
0.013 9.52±5.49 6.69±3.70 Frequency of 1 cpd, contrast of 25%, size of 30 
0.020 5.87±3.51 3.84±3.62 Frequency of 1 cpd, contrast of 5%, size of 30 
0.004 13.91±7.86 8.98±5.42 Frequency of 2 cpd, contrast of 100%, size of 15   
0.001 12.8±5.37 6.36±4.49 Frequency of 2 cpd, contrast of 50%, size of 15   
0.001 9.58±5.34 4.46±4.25 Frequency of 2 cpd, contrast of 25%, size of 15  
0.002 8.42±4.97 5.20±3.50 Frequency of 4 cpd, contrast of 100%, size of 7 
0.018 2.48±2.17 1.42±1.23 Frequency of 4cpd contrast 5% size 7 
* Standard deviation 
 
P-value Normal (mean±SD) Patient (mean±SD*) P100 latency (ms) 
0.004 105.51±7.17 111.94±10.76 Frequency of 1 cpd, contrast of 50%, size of 30 
0.002 108.87±9.42 117.45±13.01 Frequency of 1 cpd, contrast of 25%, size of 30  
* Standard deviation 
 
 
Table2. Comparison of extracted descriptors of P100 (7P) from Haar, Daubechies 2, Daubechies 4, Symlet 5, Biorthogonal 3.5, 
Biorthogonal 4.4, and Coiflet 5 scalogram analysis for all signals. 
 
Effect 
Size 
P-value* 
Normal group 
(mean±SD) 
Patient group 
(mean±SD) 
Wavelet Descriptor 7P** 
0.075 0.761 51.94±39.18 54.75±34.83 Haar The frequency of 4 cpd, contrast 5%, size7  
0.236 0.334 55.17±34.16 46.91±35.56 Haar The frequency of 2 cpd, contrast 5%, size 15  
0.035 0.885 54.45±36.75 55.69±32.24 Haar The frequency of 1cpd, contrast 5%, size 30  
0.340 0.174 56.97±37.42 44.71±34.57 Haar The frequency of 4 cpd, contrast 25%, size 7  
0.380 0.126 60.42±32.39 47.12±37.33 Haar The frequency of 2 cpd, contrast 25%, size 15  
0.158 0.523 55.43±40.36 49.34±36.27 Haar The frequency of 1 cpd, contrast 25%, size 30  
0.118 0.634 48.65±36.80 52.85±34.17 Haar The frequency of 4 cpd, contrast 50%, size 7  
0.026 0.914 45.04±30.88 44.10±39.53 Haar The frequency of 2 cpd, contrast 50%, size 15  
0.226 0.361 53.60±36.18 61.88±36.77 Haar The frequency of 1 cpd, contrast 50%, size 30  
0.159 0.522 52.64±34.02 47.38±32.10 Haar The frequency of 4 cpd, contrast 100%, size 7  
0.280 0.257 48.95±32.77 39.13±37.00 Haar The frequency of 2 cpd, contrast 100%, size 15  
0.015 0.951 34.96±33.92 34.44±33.92 Haar The frequency of 1 cpd, contrast 100%, size 30  
0.456 0.069 21.68±17.84 29.68±17.18 db4*** The frequency of 4 cpd, contrast 5%, size 7 
0.542 0.031 30.62±15.81 21.43±18.01 db4 The frequency of 2 cpd, contrast 5%, size 15  
0.461 0.066 30.97±16.41 23.11±17.65 db4 The frequency of 1 cpd, contrast 5%, size 30 
0.054 0.825 23.11±18.46 22.14±16.94 db4 The frequency of 4 cpd, contrast 25%, size 7  
0.143 0.564 28.21±18.99 25.57±17.73 db4 The frequency of 2 cpd, contrast 25%, size 15  
0.272 0.274 25.21±18.72 30.29±18.62 db4 The frequency of 1 cpd, contrast 25%, size 30  
0.167 0.499 20.13±17.04 23.09±18.33 db4 The frequency of 4 cpd, contrast 50%, size 7  
0.947 0.001* 35.58±16.77 19.02±18.14 db4 The frequency of 2 cpd, contrast 50%, size 15  
0.036 0.884 25.21±18.69 25.88±18.28 db4 The frequency of 1 cpd, contrast 50%, size 30  
0.448 0.049* 24.56±18.39 16.84±15.93 db4 The frequency of 4 cpd, contrast 100%, size 7  
0.166 0.503 25.69±17.23 22.91±16.14 db4 The frequency of 2 cpd, contrast 100%, size 15  
0.130 0.599 19.99±17.39 17.93±13.92 db4 The frequency of 1 cpd, contrast 100%, size 30  
0.214 0.389 34.89±32.29 41.53±29.63 db2**** The frequency of 4 cpd, contrast 5%, size 7 
0.024 0.468 32.17±25.76 31.47±31.14 db2 The frequency of 2 cpd, contrast 5%, size 15  
0.004 0.984 37.09±32.67 36.94±28.53 db2 The frequency of 1 cpd, contrast 5%, size 30  
0.247 0.323 34.44±32.42 26.94±28.09 db2 The frequency of 4 cpd, contrast 25%, size 7  
0.055 0.816 34.55±33.87 32.71±31.92 db2 The frequency of 2 cpd, contrast 25%, size 15  
0.278 0.265 43.44±36.80 33.83±32.04 db2 The frequency of 1 cpd, contrast 25%, size 30  
0.094 0.701 32.79±29.97 35.80±33.39 db2 The frequency of 4 cpd, contrast 50%, size 7  
0.134 0.731 29.24±25.73 33.12±31.75 db2 The frequency of 2 cpd, contrast 50%, size 15  
0.206 0.409 45.68±37.68 38.38±33.02 db2 The frequency of 1 cpd, contrast 50%, size 30  
0.082 0.740 30.73±29.52 33.08±27.69 db2 The frequency of 4 cpd, contrast 100%, size 7  
0.198 0.370 31.33±30.46 37.84±35.04 db2 The frequency of 2 cpd, contrast 100%, size 15 
0.229 0.381 29.21±28.10 35.89±30.04 db2 The frequency of 1 cpd, contrast 100%, size 30  
0.118 0.633 39.91±31.79 43.50±28.90 sym5***** The frequency of 4 cpd, contrast 5%, size 7  
0.176 0.498 32.66±28.64 37.79±29.60 sym5 The frequency of 2 cpd, contrast 5%, size 15  
a) 
b) 
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Effect 
Size 
P-value* 
Normal group 
(mean±SD) 
Patient group 
(mean±SD) 
Wavelet Descriptor 7P** 
0.075 0.761 51.94±39.18 54.75±34.83 Haar The frequency of 4 cpd, contrast 5%, size7  
0.236 0.334 55.17±34.16 46.91±35.56 Haar The frequency of 2 cpd, contrast 5%, size 15  
0.035 0.885 54.45±36.75 55.69±32.24 Haar The frequency of 1cpd, contrast 5%, size 30  
0.340 0.174 56.97±37.42 44.71±34.57 Haar The frequency of 4 cpd, contrast 25%, size 7  
0.380 0.126 60.42±32.39 47.12±37.33 Haar The frequency of 2 cpd, contrast 25%, size 15  
0.158 0.523 55.43±40.36 49.34±36.27 Haar The frequency of 1 cpd, contrast 25%, size 30  
0.118 0.634 48.65±36.80 52.85±34.17 Haar The frequency of 4 cpd, contrast 50%, size 7  
0.026 0.914 45.04±30.88 44.10±39.53 Haar The frequency of 2 cpd, contrast 50%, size 15  
0.226 0.361 53.60±36.18 61.88±36.77 Haar The frequency of 1 cpd, contrast 50%, size 30  
0.159 0.522 52.64±34.02 47.38±32.10 Haar The frequency of 4 cpd, contrast 100%, size 7  
0.280 0.257 48.95±32.77 39.13±37.00 Haar The frequency of 2 cpd, contrast 100%, size 15  
0.015 0.951 34.96±33.92 34.44±33.92 Haar The frequency of 1 cpd, contrast 100%, size 30  
0.456 0.069 21.68±17.84 29.68±17.18 db4*** The frequency of 4 cpd, contrast 5%, size 7 
0.542 0.031 30.62±15.81 21.43±18.01 db4 The frequency of 2 cpd, contrast 5%, size 15  
0.461 0.066 30.97±16.41 23.11±17.65 db4 The frequency of 1 cpd, contrast 5%, size 30 
0.054 0.825 23.11±18.46 22.14±16.94 db4 The frequency of 4 cpd, contrast 25%, size 7  
0.143 0.564 28.21±18.99 25.57±17.73 db4 The frequency of 2 cpd, contrast 25%, size 15  
0.272 0.274 25.21±18.72 30.29±18.62 db4 The frequency of 1 cpd, contrast 25%, size 30  
0.167 0.499 20.13±17.04 23.09±18.33 db4 The frequency of 4 cpd, contrast 50%, size 7  
0.947 0.001* 35.58±16.77 19.02±18.14 db4 The frequency of 2 cpd, contrast 50%, size 15  
0.036 0.884 25.21±18.69 25.88±18.28 db4 The frequency of 1 cpd, contrast 50%, size 30  
0.198 0.424 38.66±27.89 44.22±28.02 sym5 The frequency of 1 cpd, contrast 5%, size 30  
0.576 0.039* 47.48±26.27 32.76±25.60 sym5 The frequency of 4 cpd, contrast 25%, size 7  
0.114 0.644 36.19±29.53 39.68±31.21 sym5 The frequency of 2 cpd, contrast 25%, size 15  
0.097 0.696 42.17±34.90 38.99±30.17 sym5 The frequency of 1 cpd, contrast 25%, size 30  
0.002 0.991 41.11±32.26 41.02±33.35 sym5 The frequency of 4 cpd, contrast 50%, size 7  
0.250 0.314 34.51±28.04 41.61±28.73 sym5 The frequency of 2 cpd, contrast 50%, size 15  
0.242 0.333 46.38±35.97 38.43±29.30 sym5 The frequency of 1 cpd, contrast 50%, size 30  
0.040 0.872 38.26±30.56 37.11±26.35 sym5 The frequency of 4 cpd, contrast 100%, size 7  
0.340 0.172 32.23±31.07 42.81±31.01 sym5 The frequency of 2 cpd, contrast 100%, size 15  
0.096 0.698 36.08±33.76 33.00±30.07 sym5 The frequency of 1 cpd, contrast 100%, size 30  
0.0003 0.998 28.69±26.91 28.68±27.85 bior3.5****** The frequency of 4 cpd, contrast 5%, size 7  
0.574 0.024* 37.00±24.79 23.82±20.95 bior3.5 The frequency of 2 cpd, contrast 5%, size 15  
0.251 0.312 45.76±24.47 39.64±24.16 bior3.5 The frequency of 1 cpd, contrast 5%, size 30  
0.106 0.434 30.49±27.75 33.44±27.90 bior3.5 The frequency of 4 cpd, contrast 25%, size 7 
0.091 0.709 33.04±25.40 30.63±27.05 bior3.5 The frequency of 2 cpd, contrast 25%, size 15  
0.095 0.699 41.13±26.82 38.62±25.60 bior3.5 The frequency of 1 cpd, contrast 25%, size 30  
0.157 0.523 39.23±26.19 34.86±29.13 bior3.5 The frequency of 4 cpd, contrast 50%, size 7  
0.448 0.042* 37.91±24.14 26.87±25.09 bior3.5 The frequency of 2 cpd, contrast 50%, size 15  
0.068 0.783 40.02±30.97 37.97±28.89 bior3.5 The frequency of 1 cpd, contrast 50%, size 30  
0.070 0.775 35.66±28.64 37.69±28.96 bior3.5 The frequency of 4 cpd, contrast 100%, size 7  
0.110 0.656 34.83±28.64 38.09±30.43 bior3.5 The frequency of 2 cpd, contrast 100%, size 15  
0.041 0.871 29.22±25.70 30.32±27.91 bior3.5 The frequency of 1 cpd, contrast 100%, size 30  
0.614 0.024* 36.34±24.44 51.58±25.15 bior4.4******* The frequency of 4 cpd, contrast 5%, size 7  
0.129 0.601 44.24±31.73 40.17±30.88 bior4.4 The frequency of 2 cpd, contrast 5%, size 15  
0.329 0.187 49.42±33.92 38.38±33.10 bior4.4 The frequency of 1 cpd, contrast 5%, size 30  
0.436 0.083 43.79±31.58 30.63±28.68 bior4.4 The frequency of 4 cpd, contrast 25%, size 7  
0.203 0.410 44.32±31.96 37.41±35.79 bior4.4 The frequency of 2 cpd, contrast 25%, size 15  
0.166 0.503 52.55±34.77 46.87±33.53 bior4.4 The frequency of 1 cpd, contrast 25%, size 30  
0.041 0.868 41.84±33.83 40.43±34.93 bior4.4 The frequency of 4 cpd, contrast 50%, size 7  
0.554 0.024* 53.73±29.53 36.67±31.96 bior4.4 The frequency of 2cpd contrast 50%, size 15  
0.093 0.705 45.22±32.13 42.12±34.11 bior4.4 The frequency of 1 cpd, contrast 50%, size 30  
0.863 0.005* 48.14±27.37 26.84±21.67 bior4.4 The frequency of 4 cpd, contrast 100%, size 7  
0.019 0.935 33.35±30.28 33.97±31.76 bior4.4 The frequency of 2 cpd, contrast 100% size 15  
0.301 0.236 38.20±34.09 28.84±27.78 bior4.4 The frequency of 1 cpd, contrast 100%, size 30  
0.385 0.120 19.88±14.58 26.28±18.37 coif5******** The frequency of 4 cpd, contrast 5%, size 7  
0.690 0.015* 36.76±15.20 25.64±16.94 coif5 The frequency of 2 cpd, contrast 5%, size 15  
0.548 0.031* 31.70±20.60 21.27±17.27 coif5 The frequency of 1 cpd, contrast 5% size 30,  
0.172 0.478 24.41±18.72 21.27±17.61 coif5 The frequency of 4 cpd, contrast 25%, size 7  
0.012 0.961 25.13±18.17 24.89±21.02 coif5 The frequency of 2 cpd, contrast 25%, size 15  
0.122 0.622 24.29±19.97 26.78±20.79 coif5 The frequency of 1 cpd, contrast 25%, size 30  
0.186 0.449 19.40±16.25 22.80±19.97 coif5 The frequency of 4 cpd, contrast 50%, size 7  
0.728 0.007* 35.20±18.37 21.97±17.94 coif5 The frequency of 2 cpd, contrast 50%, size 15  
0.122 0.620 23.73±17.92 26.02±19.54 coif5 The frequency of 1 cpd, contrast 50%, size 30  
0.679 0.015* 28.82±16.17 17.65±16.68 coif5 The frequency of 4 cpd, contrast 100%, size 7  
0.153 0.535 24.31±16.67 21.62±18.27 coif5 The frequency of 2 cpd, contrast 100%, size 15  
0.133 0.592 17.95±16.17 20.01±14.70 coif5 The frequency of 1 cpd, contrast 100%, size 30  
 
* Significant difference (P<0.05), ** Descriptor of P100 amplitude, *** Daubechies 4, **** Daubechies 2, ***** Symlet 5, ****** 
Biorthogonal 3.5, ******* Biorthogonal 4.4, ******** Coiflet 5 
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Table3. Comparison of normal individuals and patients with amblyopia  
 
Stimuli condition Amplitude coif5* db4** bior4.4*** bior3.5**** 
1 cpd, contrast 5%   0.02 0.015 - - - 
2 cpd, contrast 50% 0.001 0.007 0.001 0.024 0.042 
4 cpd, contrast 100%  0.002 0.017 0.049 0.005 - 
4 cpd, contrast 5% 0.018 - - 0.024 - 
* Coiflet 5, ** Daubechies 4, *** Biorthogonal 4.4, **** Biorthogonal 3.5 
 
 
Table4. Significant correlations between different spatial frequencies at the same contrast 
 
Significance Pearson Correlation Spatial frequency (cpd) Contrast Wavelet 
0.036 0.259 (1,2) 5% db4* 
0.015 0.299 (2,4) 25% bior4.4** 
0.049 0.244 (2,4) 25% coif5*** 
* Daubechies 4, ** Biorthogonal 4.4, *** Coiflet 5 
 
 
 
Discrete Wavelet Transform 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Descriptors extracted from the discrete wavelet transform scalograms. Right: 15˚ arc, 2 cpd, 50% stimuli, Coiflet 5 (coif5) 
scalogram. Left: 7˚ arc, 4 cpd, 100% stimuli, coif5 scalogram. 7P in level 7 (regions with white borders) include a single wavelet coefficient 
and is equal to the energy percentage of single wavelet coefficient to the total energy of level 7. A jet color map is used in which the darkest 
red color corresponds to high wavelet coefficients and the darkest blue color denotes low wavelet coefficients (color bars are placed on the 
right side of each scalogram). 
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Figure 2. The significant difference in 7P between healthy and pathological small stimuli signals extracted from discrete wavelet 
transform (DWT) scalograms using Coiflet 5, 1 cpd and 5% stimuli (right: control group, left: patients group). Deep dark red rectangles 
denote higher energy components of the DWT scalogram and blue ones show low energy (color bars placed on the right-hand side of each 
scalogram). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Original signal (solid line) and reconstructed signal (dashed line) by Coiflet 5 (right: normal, left: patient) at the frequency of 1 
cpd and the contrast of 5% stimuli. 
 
Discussion 
According to the literature and the similarity of 
mother wavelets with PRVEP waveforms, we 
performed the DWT of the PRVEPs of normal 
subjects and patients using Haar, db2, db4, bior3.5, 
bior4.4, sym5, and coif5 [33-37].  
Consistent with previous investigations, P100 
amplitude was reduced in the patients with 
amblyopia [17, 19 and 40]. Talebnejad et al. assessed 
VEP signals in the dimension of time in patients with 
anisometropic amblyopia and normal individuals 
with P100 amplitude, 15˚ and 60˚ arc, and the 
contrast levels of 30% and 100% stimuli. They 
showed amplitude reduction at high spatial 
frequency, contrast of 100%, and low spatial 
frequency (P pathway), and contrast of 30% (M 
pathway) in patients with anisometropic amblyopia 
[17]. Due to P100 generator, the reduction of 
amplitude demonstrates the extent of damage at 
visual cortex, as well as M and P pathways [49-51].  
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P100 latency (Table 1b) increased in the patients 
group which was in line with previous studies [18, 40, 
and 50]. Hosseinmenni et al. investigated P100 latency 
for four stimuli (high and low spatial frequencies with 
high and low contrast) to isolate the functions of M 
and P pathways. Their results showed the P100 
latency of abnormal signals increased significantly in 
small check size at both contrast levels. Nevertheless, 
there was a significant increase in large check size at 
high contrast level [18]. Latency elongation was an 
indicator of visual pathway malfunction. Moreover, 
this increase may be related to delay post retinal 
neural conduction [1, 18, and 46]. 
The contrasts of 50% and 100%, the spatial 
frequencies of 2 cpd and 4 cpd were appropriate for 
differentiating normal and abnormal signals in 
wavelet domain, respectively (Table 2). In the 
contrast of 5%, 7P decreased at 1 cpd and 2 cpd, as 
well as the contrast of 25% at 2 cpd in the patients 
group. As mentioned above, M pathway neurons are 
sensitive to low contrasts; accordingly, this decrease 
can show the predominance of magnocellular 
dysfunction in these stimuli. These results were in 
accordance to previous studies [2, 23, and 52]. 
Considering the fact that the P pathway neurons 
response to higher contrasts, the dominance of 
damage in these cells can cause 7P reduction at the 
contrast of 50% and the frequency of 2 cpd. In the 
same way, marked decrease of 7P at the contrast of 
100% and the frequency of 4 cpd can confirm it [53, 
54].  
However, contrary to the other results, VEP 
analysis by bior4.4 showed an increase in 7P of 
abnormal signals arising from the frequency of 4 cpd 
and the contrast of 5%. It can be due to the activation 
of other neurons of visual system that have 
response-sensitivity relationship similar to M and P 
cells [55]. 
It can be offered that signal analysis in time-
frequency domain can complete time domain 
analysis (Table 3). Since the analyzed parameters in 
both domains showed significant differences at the 
frequencies of 2 cpd and 4 cpd and the contrast of 
50% and 100%, they can be considered as optimal 
stimuli. Furthermore, coif5 and bior4.4 are favorite 
wavelets due to their results and time domain of 
ones had better overlapping.  
The results of the present study were in line with 
other studies and indicated that anisometropic 
amblyopia affected both P (at higher contrasts) and 
M pathways (at lower contrasts) [17, 18, and 56]. 
Some investigations have suggested that P pathway 
is dominant in amblyopic defects [10, 53], while our 
findings prove damages of both systems which 
reflect abnormal cortical post lateral geniculate 
nucleus process of retinal signals [52].  
The significantly different means at a specific 
spatial frequency and contrasts determined that the 
P and M systems were isolated. Therefore, a 
combination of both systems most likely leads to 
insignificant differences in some cases. According to 
the results, it seems that the DWT with coif5, bior4.4, 
db4, and bior3.5 wavelets can be suggested as a 
technique to distinguish between M and P pathways. 
In addition, using stimuli with the contrast of 50% 
and the spatial frequency of 2 cpd could provide the 
best clues to the diagnosis of amblyopia.  
 
Limitations of the Study 
Finding patients considering the age and visual 
acuity range with similar disease paradigm was an 
important limitation. Accordingly, our sample size 
was small and the standard deviation was high. 
Transferring data was another major problem. As a 
result, adding WT to systems would facilitate 
analysis. 
 
Conclusion 
The DWT analysis of the PRVEP for figuring out 
optimum spatial frequency and contrast can help 
physicians to select an appropriate stimulus to 
monitor the visual function of anisometropic 
amblyopia. The WT can be considered as a 
complement of the time domain to optimize stimuli 
for separating normal and pathological signals. 
Further studies are recommended to evaluate 
wavelets with a larger sample size. 
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